Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0677930 (
primary tumor
)
20,210
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
NK cells are most effective in killing a broad spectrum of
primary tumor
cells after stimulation with cytokines. We have cloned a novel gene, designated
NKLAM
(for NK lytic-associated molecule), whose expression is associated with this cytokine-enhanced process.
NKLAM
expression is up-regulated in NK cells by IL-2 and IFN-beta.
NKLAM
is also selectively expressed by activated macrophages and CTL. Treatment of NK cells and CTL with
NKLAM
antisense oligonucleotides specifically decreases their cytolytic activity, while having no effect on cell growth. The
NKLAM
gene encodes a 62-kDa ring finger-containing protein that localizes to the cytoplasmic granules in NK cells. Further study of this gene may add to our understanding of cytotoxic processes common to NK cells, CTL, and activated macrophages.
...
PMID:NK lytic-associated molecule: a novel gene selectively expressed in cells with cytolytic function. 1043 9